SLC22A2 and colorectal neoplasm: Importantly, prior transcriptional profiling of drug transporters using RNA sequencing data (27) revealed that OCT2 is expressed at very low levels in human colorectal tumors and colorectal cancer cell lines compared to expression levels in DRG neurons (3).